AVH 0.32% $3.09 avita medical inc.

FDA timing and the summer holidays, page-2

  1. 2,725 Posts.
    lightbulb Created with Sketch. 270
    Hi jessica211,

    It is not wishful thinking. If you refer to page 10 of "Annual General meeting Presentation" dated 30/11/2017, it said the following:

    PMA filed 28 Sep 2017
    - Granted priority review
    - 90% of PMAs without advisory committee reach decision 180 FDA days after filing
    - 90% of PMAs with advisory reach decision 320 FDA days after filing.
    - Consistent engagement with FDA through Expedited Access Pathway (EAP) has reduced regulatory risk.

    We are now into about 260 days since filing and based on the above, I suspect we will hear the decision between July and September. I am actually surprised why it takes so long and we haven't got a decision now, cause of our EAP status and granted priority review??? It is a bit disappointing though.
 
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.